A1LZU

[2,6-di(propan-2-yl)phenoxy]methyl dihydrogen phosphate

Created:	2024-03-29
Last modified:	2024-05-22

Find Related PDB Entry
1 entries where A1LZU is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	40
Chiral Atom Count	0
Bond Count	40
Aromatic Bond Count	6

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	[2,6-di(propan-2-yl)phenoxy]methyl dihydrogen phosphate
Systematic Name (OpenEye OEToolkits)	[2,6-di(propan-2-yl)phenoxy]methyl dihydrogen phosphate
Formula	C₁₃ H₂₁ O₅ P
Molecular Weight	288.277
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CC(C)c1cccc(C(C)C)c1OCO[P](O)(O)=O
SMILES	OpenEye OEToolkits	2.0.7	CC(C)c1cccc(c1OCOP(=O)(O)O)C(C)C
Canonical SMILES	CACTVS	3.385	CC(C)c1cccc(C(C)C)c1OCO[P](O)(O)=O
Canonical SMILES	OpenEye OEToolkits	2.0.7	CC(C)c1cccc(c1OCOP(=O)(O)O)C(C)C
InChI	InChI	1.06	InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16)
InChIKey	InChI	1.06	QVNNONOFASOXQV-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB06716
Name	Fospropofol
Groups	approved illicit investigational
Description	Fospropofol is a water soluble prodrug and is converted to propofol in the liver. Fospropofol is a short acting hypnotic/sedative/anesthetic agent. Unlike propofol, does not cause injection-site pain as it is unable to activate TRPA1. FDA approved in December 2008. Fospropofol is a Schedule IV controlled substance in the United States under the Controlled Substances Act.
Synonyms	Fospropofol Fospropofol disodium
Brand Names	Lusedra
Indication	For monitored anaesthesia care sedation in patients undergoing diagnostic procedures like bronchoscopy and colonscopy or minor surgical procedures like arthroscopy and bunionectomy.
Categories	Agents that reduce seizure threshold Anesthetics Anesthetics, General Benzene Derivatives Central Nervous System Agents Central Nervous System Depressants Hypnotics and Sedatives Phenols
CAS number	258516-89-1

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Gamma-aminobutyric acid receptor subunit beta-2	MWRVRKRGYFGIWSFPLIIAAVCAQSVNDPSNMSLVKETVDRLLKGYDIR...	unknown	potentiator
Gamma-aminobutyric acid receptor subunit beta-3	MWGLAGGRLFGIFSAPVLVAVVCCAQSVNDPGNMSFVKETVDKLLKGYDI...	unknown	potentiator
Serum albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682